Electra Therapeutics, Inc. (ETRA)
NASDAQ: ETRA · Real-Time Price · USD
8.94
+0.33 (3.83%)
At close: Oct 14, 2026, 4:00 PM EDT
9.00
+0.06 (0.67%)
Pre-market: Oct 15, 2026, 7:00 AM EDT

Electra Therapeutics Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Electra Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $33.33. The average 1-year stock price forecast is 272.82% higher than the current stock price, while the lowest is $32 (+257.94%) and the highest is $36 (+302.68%).

Price Target: $33.33 (+272.82%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$32$33.33$32$36
Change+257.94%+272.82%+257.94%+302.68%

Analyst Ratings

The average analyst rating for Electra Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingOct '26
Strong Buy4
Buy0
Hold0
Sell0
Strong Sell0
Total4

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
n/a
BuyInitiatesn/an/aOct 13, 2026
TD Cowen
TD Cowen
Buy
Initiates
n/a
BuyInitiatesn/an/aOct 13, 2026

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2024FY 2025FY 2026
Period EndingDec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
---
Operating Income
-26.32M-61.89M-110.80M
Net Income
-24.79M-61.98M-107.73M
Free Cash Flow
---98.00M
No. Analysts
--4

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-
Avg-
Low-

EPS Growth

EPS Growth20272028
High-
Avg-
Low-